SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower following the government's proposal for an unexpectedly minimal increase in 2027 Medicare Advantage payment rates, sparking broad concerns across the health insurance sector. While many view the significant sell-off as an overreaction and a long-term buying opportunity due to strong fundamentals, others anticipate further declines, highlighting policy risk and the ongoing political scrutiny on healthcare profitability.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending due to its recent surge to new all-time highs, fueled by increasing geopolitical instability, a depreciating US Dollar, and heightened central bank demand for physical gold. The community is sharply divided, debating whether this parabolic move is a legitimate hedge against fiat currency debasement or a speculative 'mania' ripe for a significant pullback.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics ($RR) is capturing significant attention following its collaboration with Microsoft's AI Co-Innovation Labs to integrate advanced agentic AI into its ADAM robot, highlighting a pivotal development in the robotics sector. The community is actively discussing the potential for a sustained rally and short squeeze, though some express skepticism about the full impact of the partnership on the company's valuation.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is a major talking point as strong physical demand from global governments and industries like AI and EVs drives its significant rally, exacerbated by a weaker dollar. Community members are fiercely divided, with bulls anticipating a historic short squeeze due to supply deficits and alleged manipulation, while bears warn of an unsustainable bubble poised for a sharp correction.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is a hot topic as its earnings report approaches, with the early release date fueling strong community speculation about a significant new deal, potentially with a hyperscaler like Amazon or AWS. Investors are optimistic, anticipating IREN's strategic pivot to AI infrastructure will unlock substantial value given the high demand for GPU-centric data capacity. Many believe the company is well-positioned in the rapidly expanding AI cloud sector, despite discussions around its historical correlation to Bitcoin price movements.

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

GRI Bio Inc. is actively trending following its recent 1-for-28 reverse stock split, which has created an exceptionally low float of approximately 500k shares. This development, coupled with recently announced positive Phase 2a clinical data and secured funding, is driving intense community discussion: many anticipate a significant short squeeze comparing it to prior low-float runners, while others express deep skepticism citing the company's history of frequent dilutions and management's perceived lack of trustworthiness.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending amid growing community excitement fueled by recent institutional interest, including a notable ownership stake by Bank of Nova Scotia and increased ETF allocations. Investors are eagerly anticipating significant "contract news" for its high-performance computing (HPC) data centers, hoping to see the company re-rated as a pure-play AI infrastructure provider rather than solely a Bitcoin miner. This anticipation is driving discussions around its potential to lead in the energy-intensive computing sector.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is generating significant buzz following analyst endorsements recognizing its AI/HPC colocation strategy and major contracts with hyperscalers. The community highlights strong institutional interest and buying pressure, viewing the stock as increasingly driven by its data center expansion rather than solely by Bitcoin's fluctuations, with many anticipating substantial upside.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

Flora Growth Corp. is generating significant buzz as it rebrands to ZeroStack Corp., signaling a strategic pivot towards an AI-focused asset management company with a substantial treasury of 0G decentralized AI tokens. The community is actively discussing the company's ultra-low float and perceived undervaluation, driven by the value of its crypto assets relative to its market capitalization. This has fueled widespread speculation for a potential explosive move, with many closely watching the recently approved forward stock split as a sign of management's confidence in future growth.

BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.

BiomX Inc

BiomX Inc. is experiencing significant buzz following a 13D filing that disclosed Pyu Pyu Capital's substantial 19.99% stake, amplified by discussions suggesting the company has ceased its ATM share offerings. The investing community is keenly focused on the stock's extremely low float, actively debating a potential short squeeze and rapid upward movement, drawing parallels to other recent micro-cap biotech rallies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Matt Harrison

Henke

Dead Broke

$CXAI its so undervalued its crazy, so many huge pr&#39;s lately and price has gone down everyday for years untill now when its time to keep on grinding upwards. Reminds me when $RR  was in the low $.30 tbh.. 
 
https://globalinkz.com/article/cxais-landmark-deployment-signals-trillion-dollar-shift-to-agentic-ai-workplaces 
 
ai trend $BNAI $NVDA $VTIX on watch!

CXAI's 30,000-user enterprise rollout shows 96% desk utilization and 85% weekly retention, proving agentic AI can turn office disruption into billion-dollar productivity gains.